Purchases and Sales Made in Q4 2022 in Northwest Biotherapeutics Inc (NWBO)
This table provides information about the institutional ownership of Northwest Biotherapeutics Inc (NWBO) during Q4 2022. The information is specifically focused on institutions that hold shares of NORTHWEST BIOTHERAPEUTICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 15, 2023
Q4 2022
|
Sentinus, LLC
Oak Brook, IL |
BUY
|
- |
600K+ 50.27% |
$396K - $690K
|
1.79M
$485K
|
|
|
Feb 14, 2023
Q4 2022
|
Ancora Advisors, LLC
Cleveland, OH |
BUY
|
- |
29K+ 5.84% |
$19.1K - $33.4K
|
526K
$142K
|
|
|
Feb 09, 2023
Q4 2022
|
Mai Capital Management
|
BUY
|
- |
20KNew |
$13.2K - $23K
|
20K
$5.4K
|
|
|
Feb 03, 2023
Q4 2022
|
Advisors Management Group Inc
|
BUY
|
- |
10.3KNew |
$6.78K - $11.8K
|
10.3K
$2.77K
|
|
|
Feb 14, 2023
Q4 2022
|
Williams Jones Wealth Management, Llc.
New York, NY |
BUY
|
- |
5K+ 12.82% |
$3.3K - $5.75K
|
44K
$11.9K
|
|
|
Jan 18, 2023
Q4 2022
|
Opus Capital Group, LLC
|
BUY
|
- |
5K+ 9.07% |
$3.3K - $5.75K
|
60.2K
$16.2K
|
|
|
Jan 30, 2023
Q4 2022
|
Moloney Securities Asset Management, LLC
|
BUY
|
- |
300+ 0.11% |
$198 - $345
|
285K
$77.1K
|